More on Albert Pujols' upside as a future manager, the Brewers' curious offseason, and the Rays' potential next star as well.

REGENXBIO Inc. today announced data from its RGX-121 (clemidsogene lanparvovec) program for the treatment of mucopolysaccharidosis type II (MPS II), also known as Hunter syndrome, will be shared at ...